L.B. NOVIKOVA¹, A.P. AKOPYAN¹, K.M. SHARAPOVA^1,2

¹Bashkir State Medical University, 3 Lenin Str., Ufa, Russian Federation, 450000

²Emergency Hospital, 39/2 Batyrskaya Str., Ufa, Russian Federation, 450000 

Novikova L.B. ― D. Med. Sc., Professor, Head of the Department of Neurology and Neurosurgery, tel. (8347) 255-10-38, e-mail: novicova@inbox.ru

Аkopyan A.P. ― Cand. Med. Sc., Associate Professor of the Department of Neurology and Neurosurgery, tel. (8347) 255-10-38, e-mail: ano-akopian@yandex.ru

Sharapova K.M. ― Assistant of the Department of Neurology and Neurosurgery, tel. +7-917-485-26-86, e-mail: karinasharapova87@gmail.com

Parkinson’s disease (PD) is the second most common neurodegenerative disorder of humans. BP can be considered a monogenic and multifactor disease. Epidemiological studies indicate that Parkinson’s disease occurs in all ethnic groups and occurs at different rates in men and women. According to WHO, more than 4 million people in the world suffer from BP. At the same time, the number of cases steadily increases as well as the number of patients older than 60 y.o. The increased incidence of this disease in the world is associated with the increase in life span, but other factors (e.g., environmental) may be significant, too. There are difficulties with the diagnosis of the disease, especially at the early stages, as the diagnosis of PD is made mainly on the basis of clinical manifestations and the course of disease. The article presents the results of clinical and epidemiological studies of Parkinson’s disease (PD) in Bashkortostan in 2013-2015 ― the prevalence in various age and gender groups, and provision of medicines in the Republic of Bashkortostan. The prevalence of PD in Bashkortostan amounted to 45.1, 48.7 and 40.0 cases per 100 000 population in 2013, 2014 and 2015, respectively.

Key words: Parkinson’s disease, prevalence, age, gender, treatment.

REFERENCES

1. Levin O.S, Fedorova N.V. Bolezn’ Parkinsona. 6-e izd. [Parkinson’s disease. 6th ed]. Moscow: MEDPress-inform, 2016. 384 p.
2. Levin O.S. Diagnosis and treatment of Parkinson’s disease: the edge of the problem. Meditsinskiy sovet, 2015, no. 18, pp. 2-6 (in Russ.).
3. Levin O.S., Dokadina L.V. Epidemiology of Parkinsonism and Parkinson’s Disease. Nevrologicheskiy zhurnal, 2005, 5, pp. 41-48.
4. Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M. et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 2007, 68, pp. 384-386.
5. Driver J.A., Logroscino G., Gaziano J.M., Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology, 2009, 72, pp. 432-438.
6. Karabanov A.V., Illarioshkin S.N. Application of Mirapaks PD in Parkinson’s disease. Nervnye bolezni, 2014, no. 3, pp. 29-32 (in Russ.).
7. Novikova L.B., Akopyan A.P., Sharapova K.M. Prevalence of Parkinson’s Disease in the Republic of Bashkortostan. Vestnik BGMU, 2015, no. 2, suppl., pp. 1417-1422.
8. Katunina E.A., Bezdol’nyy Yu.N. Epidemiologicheskie issledovaniya parkinsonizma: Metodicheskie rekomendatsii [Epidemiological studies of parkinsonism: Methodological recommendations]. Moscow: Rossiyskiy gosudarstvennyy meditsinskiy universitet, 2010. 43 p.
9. Katunina E.A., Avakyan G.N., Bezdol’nyy Yu.N., Ismailov A.M. et al. Epidemiology of Parkinsonism. Zhurnal Nevrologii i Psikhiatrii, 2009, 11, pp. 76-80 (in Russ.).
10. Obukhova A.V. Modern therapy of Parkinson’s disease. Nevrologiya, neyropsikhiatriya, psikhosomatika, 2014, no. 3, pp. 80-84 (in Russ.).